CORONAVIRUS NEWS
FDA to approve COVID drug for phase III trials
Carrimycin, a synthetic biological drug treatment for severe COVID-19, is to receive US Food and Drug Administration (FDA) approval for Phase III trials.
COVID-19 linked with higher death rate in acute heart failure patients
Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
Ethical guidance published for frontline staff dealing with pandemic
The Royal College of Physicians has published ethical guidance for frontline staff dealing with the COVID-19 pandemic, supported by more than a dozen other health organisations.
GPs Given £10 Per Jab Boost To Support Vaccination Drive
The NHS is to provide GPs an extra £10 for every care home resident they are able to vaccinate against COVID by the end of January in an accelerated drive to protect the most vulnerable.
Oxford University/AstraZeneca vaccine authorised by MHRA
The Government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use.
New guideline on managing the long-term effects of COVID-19
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
Over 600,000 people get first dose of Pfizer/BioNTech vaccine
The Government has published figures which show the number of people who have received the vaccine between 8 December and 20 December in the UK is 616,933.
Pregnant women excluded from three-quarters of COVID treatment trials
Pregnant women are among those most in need of safe, effective therapies against COVID-19, but they are routinely excluded from the majority of clinical treatment trials, according to authors of a paper, published in The Lancet Global Health journal.
New poll finds BAME groups less likely to want COVID vaccine
A new poll by the Royal Society for Public Health has revealed that three in four (76%) of the UK public would take a COVID-19 vaccine if advised to do so by their GP or health professional, with just 8% stating they would be very unlikely to do so.
Over 137,000 people receive first dose of COVID vaccine in one week
More than 137,000 people in the UK have received the first dose of the Pfizer/BioNTech COVID-19 vaccine in the first week of the largest vaccination programme in British history.
Machine learning helps develop more accurate COVID-19 diagnostic tool
Researchers at the University of Maryland, Baltimore County (UMBC) have developed a method of generating high-quality chest X-ray images that can be used to diagnose COVID-19 more accurately than current methods.
Portable digital chest drainage systems could minimise COVID spread
A team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust has uncovered important findings on the use of chest drains during the COVID pandemic.
Interim trial results published for Oxford vaccine
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases
Cancer risk factors for mortality following COVID
Cancer and cancer treatment are both independent risk factors for mortality following COVID-19 infection, according to UCLH led research which highlights the ongoing need to protect cancer patients during the pandemic.
COVID infections fall by over 50% in the North West and North East
Interim results from the seventh report of one of the country’s largest studies into COVID-19 infections in England have been published by Imperial College London and Ipsos MORI.
COVID-19: study highlights importance of early use of CPAP
The lives of patients hospitalised with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Sheffield Trust chosen to lead major Covid-19 vaccine trial
Sheffield Teaching Hospitals NHS Foundation Trust is one of 17 sites across the country, and the only one in the Yorkshire and Humber, to have been selected to trial the latest Covid-19 candidate vaccine.
UCL steps up testing of immune response in care homes
The Vivaldi 2 study will more than triple in size to provide a detailed picture of coronavirus infection in care homes in England.
Beckman Coulter launches its SARS-CoV-2 IgM antibody test
Beckman Coulter has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.
UK ramps up vaccine manufacture capabilities
The Vaccines Manufacturing and Innovation Centre (VMIC) has announced rapid expansion of recruitment, in order to meet anticipated demand in 2021.
Featured Supplier
MMM has been operating worldwide as one of the leading system providers in the service of health since 1954. With a full portfolio of products and services pertaining to sterilization & disinfection systems for hospitals, scientific institutes, laboratories & the pharmaceutical industry, MMM has positioned itself as a crucial quality driver.
Upcoming Events
EBME Expo 2022
Coventry Building Society Arena, Phoenix Way, Rowleys Green, Coventry CV6 6GE
28th - 29th June
Infection 360: What's trending in infection prevention & control
Edgbaston Stadium, Birmingham
27-28 September 2022
IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022
Bournemouth
17-19 October 2022
UKHCA Conference: Listen Up
Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022
MEDICA 2022
Dusseldorf Germany
14th November - 17th November
Future Surgery 2022
ExCel, London
15th - 16th November 2022
Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.
Download the FREE Clinical Services Journal app from your device's App store
